You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Presenters at ASM have used next-generation sequencing to examine Ebola, Zika, and respiratory virus infection and transmission.
The tool has been applied to determine the pathogenic cause of hemorrhagic fever, and is powering a new test for respiratory disease pathogens.
In Nature this week: reverse genetics used to gauge phenotypes of loss-of-function mutations, and more.
The virus spread according to a gravity model between large population centers, and its movements were affected by geographical distance.
In Genome Biology this week: epigenetic differences in CML cells, predicting aggressive prostate cancer, and more.
An international team of researchers examined differential gene expression in blood samples from patients infected during the West African outbreak.
In Cell this week: Ebola virus improved ability to infect humans during recent outbreak, and more.
The Ebola virus may have mutated to better infect humans during the 2014 outbreak, the New York Times reports.
US Army scientists have developed a way to more precisely determine the amount of antigen needed as they develop an Ebola virus-like particle vaccine.
In PLOS this week: cell-free DNA from tumors is shorter than DNA from healthy cells, type 2 diabetes-related loci, and more.
A German shepherd called Nala has had her genome sequenced.
A coronavirus serology test garners Emergency Use Authorization from the US Food and Drug Administration, but the Los Angeles Times asks: how will tests like that be used?
Certain gene variants in conjunction with a healthy lifestyle may keep brains young, according to New Scientist.
In Science this week: increased CD8 T cell density and increased IFN-gamma response may indicate metastatic prostate cancer patients who will respond to immune checkpoint blockade therapy.